Top Markets
#1 pippin pippin +16.86%
#2 Aria.AI Aria.AI +14.74%
#3 River Pts River Pts +14.68%
#4 Janction Janction +13.50%
#5 Strategic Oil Supply Strategic Oil Supply +12.21%
#6 TRIA TRIA +12.05%
#7 DeXe DeXe +11.31%
#8 Osaka Protocol Osaka Protocol +10.09%
#9 Lava Network Lava Network +8.51%
#10 Orochi Network Orochi Network +8.44%
Coin of the day
pippin pippin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rangering i aksjer #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aksjekurs
$37.45
Markedsverdi
$166.43B
Endring (1 dag)
-2.55%
Endring (1 år)
-53.09%
Land
DK
Handel Novo Nordisk A/S (NVO)

Kategori

Healthcare
Inntekter for Novo Nordisk A/S (NVO)
Inntekter i 2026 TTM: 0
Ifølge Novo Nordisk A/S sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Novo Nordisk A/S fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.45B -
NL